Hans Hull

Hans Hull

Corporate Officer/Principal at PLIANT THERAPEUTICS, INC.

Net worth: 2 M $ as of 2024-04-29

49 year
Consumer Services
Health Technology
Process Industries

Profile

Hans P.
Hull
is currently the Chief Business Officer at Pliant Therapeutics, Inc. He previously served as the President & Chief Executive Officer at Adverum Biotechnologies, Inc. from 2011 to 2015.
Prior to that, he worked as an Attorney at Heller Ehrman LLP from 2003 to 2005 and as the General Manager & Vice President at Orthobond Corp.
from 2005 to 2008.
Mr. Hull completed his undergraduate studies at Princeton University and obtained a graduate degree from Berkeley Law University of California.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-18 180,860 ( 0.30% ) 2 M $ 2024-04-29

Hans Hull active positions

CompaniesPositionStart
PLIANT THERAPEUTICS, INC. Corporate Officer/Principal 2016-02-29
All active positions of Hans Hull

Former positions of Hans Hull

CompaniesPositionEnd
ADVERUM BIOTECHNOLOGIES, INC. Chief Executive Officer 2015-11-30
Chief Executive Officer 2008-03-31
Corporate Officer/Principal 2004-12-31
See the detail of Hans Hull's experience

Training of Hans Hull

Princeton University Undergraduate Degree
Berkeley Law University of California Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hans Hull's experience

Connections

60

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
PLIANT THERAPEUTICS, INC.

Health Technology

ADVERUM BIOTECHNOLOGIES, INC.

Health Technology

Private companies2

Process Industries

Commercial Services

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW